Toyotacho sales break down by activity as follows: - sale of vehicles (90.4%); - financial services (7.8%); - other (1.8%). The geographic breakdown of sales is as follows: Japan (31.6%), Asia (16.7%), North America (34.4%), Europe (10.9%) and others (6.5%). Early 2025, the number of employees was 385,000 people¹.

Since 2020 Q2, investors are wondering if Toyota is destined to retain its global leadership. Public health policies do not only create outbreaks, they generate shortages. In an era that becomes more and more dependent on electrical energies and electronic assistance, the lack of chips¹, raw materials, compliant law weigh on the performance of manufacturers. Thus, conjunction of the effects of medicine and law translate what is happening today in order to better predict what it does not yet know produced. Since 2021, these factors have intervened in speculation, which makes them objective elements of conviction regarding the weighting of toyota securities.

First, public health policy is imposed on manufacturers. The variation in health measures has a direct effect on production capacity and therefore, on income from securities. For example, April 3, 2020 outbreak depreciated the share from $ 140 to $ 115. Immunology is, in fact, one of the strongest indications of what it is going to happen. But comparative financial data shows that over the period, General Motors and Daimler have divided their market value by three. We can see that Toyota has done better than its competitors. One can wonder - like Daimler - if cash flow management is the reason or - like Bombardier - to argue that the debt ratio would be optimal despite the volume of payroll. The fact that the underweighting of the title was less accentuated at Toyota suggests that other factors come into play in a global system partitioned by the epidemic. It is possible to deduce that in the event of a new episode of confinement, Toyota has a lower probability of loss of income than its competitors. This relative confidence must now be enlightened by the law.

Secondly, the decisions made final by the judge are binding on the private sector¹, which can be detrimental both to financial projections and to the cash flow immediately available to the management board. Concerning sanitary measures, justice is a convincing predictor for fair speculation in Toyota stocks. In fact, the Bowman vs Monsanto case of 2013 introduced¹ the notion of reasonable doubt as to the place of causation existing between a cause - use - and a final result - the disease. In the future, cross-fault liability disputes will have an impact on manufacturers. In addition, the repetition of fraud is an aggravating circumstance. In January 2021, Toyota was the subject of a $ 180 million conviction for misconduct¹ about air compliance. Despite everything, the company has the resources to absorb litigation in a medium term and act to fix them without altering its shareholder income or state loan. As earnings are quite stable, the market is likely to underweight Toyota shares. It seems opportune not to divest with it or even, to acquire some until 2023.

For all these reasons,

Toyota-shi deserves a middle upper confidence.